Persistent numbers of tetramer+ CD8+ T cells, but loss of interferon-γ+ HIV-specific T cells during progression to AIDS

Blood

Volumn 99, Issue 7, 2002, Pages 2505-2511

  Kostense, Stefan ^a,b   Vandenberghe, Kristin ^a,b   Joling, Jeanine ^a,b   Van Baarle, Debbie ^a,b   Nanlohy, Nening ^a,b   Manting, Erik ^a,b   Miedema, Frank ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; TETRAMER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0036530017     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2505     Document Type: Article

References (48)

1. + T cell effector mechanisms in resistance to infection
2. Accessing complexity: The dynamics of virus-specific T cell responses
3. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
4. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
5. Longitudinal analysis of human immunodeficiency virus type-1 (HIV-1) specific cytotoxic T lymphocyte responses: A predominant gag-specific response is associated with non-progressive infection
6. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
7. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T-lymphocytes: Correlation with disease progression
8. Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
9. Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
10. Cytotoxic T lymphocytes in HIV-1 infection: A killing paradox?
11. Phenotypic analysis of antigen-specific T lymphocytes
12. T-cell epitope mapping by flow cytometry
13. Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4 T cells
14. + T cells in HIV-infected progressors and long-term nonprogressors
15. Analysis of successful immune responses in persons infected with hepatitis C virus
16. + T cells in peripheral blood and liver using peptide-MHC tetramers
17. + memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression
18. + T cells in chronic human immunodeficiency virus infection
19. + T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS related non-Hodgkin's lymphoma
20. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon
21. + T cell expansions: Evidence for impaired CTL effector function
22. Functional impairment of simian immunodeficiency virus-specific CD8(+) T cells during the chronic phase of infection
23. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
24. Functionally inert hiv-specific cytotoxic t lymphocytes do not play a major role in chronically infected adults and children
25. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides
26. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
27. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type-1 infection
28. + T cell responses associated with control of viremia
29. + T lymphocytes
30. IL-13 and IFNg secretion by activated T cells in HIV-1 infection associated with viral suppression and lack of disease progression
31. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
32. Antagonist effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat
33. + T cells
34. + T cells specific for EBV in healthy virus carriers
35. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
36. Skewed maturation of memory HIV-specific CD8 T lymphocytes
37. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic HIV-infected men
38. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3z, the signaling chain of the T cell receptor complex
39. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3z and CD28 key signaling molecules for T cell activation
40. Viral immune evasion due to persistence of activated T cells without effector function
41. + cytotoxic T-cell responses during chronic viral infection
42. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
43. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
44. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome
45. + individuals treated with a therapeutic vaccine plus antiretrovirals in a phase II study: Two year results
46. + T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells
47. + T cell repertoire that are not immediately restored by antiviral or immune-based therapies
48. + T lymphocytes in interleukin-2-treated HIV-infected patients